Bariatric surgery strategy
ProcedureBariatric surgery including an intensive pre- and postoperative treatment scheme
NCT Number: NCT06065124
The goal of this clinical trial is to evaluate if a bariatric surgery strategy will improve clinical endpoints, cardiac parameters and functional status in patients with obesity (with BMI 32-40 kg/m2) and symptomatic HF with preserved or mildly reduced LVEF in combination with AF, as compared to standard of care. Patients will be randomized to either the Intervention group receiving bariatric surgery including an intensive pre- and postoperative treatment scheme or to the control group receiving standard of care.
Interested in participating?
Request Info45 year–70 year
All sexes
Interventional
Not applicable
Rijnstate Hospital, Arnhem, Gelderland, Netherlands
The primary objective is to study the effect of a bariatric surgery strategy on the hierarchical occurrence of: 1) all-cause mortality within 2 years, 2) emergency room visit or hospitalization for HF within 2 years, 3) recurrent ECG-documented AF within 2 years, 4) decrease of ≥30gr of left ventricular (LV) mass on transthoracic echocardiography, and 5) improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bariatric surgery including an intensive pre- and postoperative treatment scheme
Time frame: 2 years
The hierarchical occurrence of: 1) All-cause mortality; 2) Emergency room visit or hospitalization for HF; 3) Recurrent ECG-documented AF; 4) Decrease of ≥30gr of LV mass on transthoracic echocardiography; 5) Improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (Scores are transformed to a range of 0-100, in which higher scores reflect better health status)
Time frame: 2 years
All-cause mortality
Time frame: 2 years
Emergency room visit or hospitalization for HF
Time frame: 2 years
Recurrent AF documented on ECG
Time frame: 2 years
Decrease of ≥30gr of LV mass measured by transthoracic echocardiography
Time frame: 2 years
Improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (scores are transformed to a range of 0-100, in which higher scores reflect better health status)
Time frame: 2 years
Measuring weight during clinical trial
Time frame: 2 years
Medication changes after surgery
Time frame: 2 years
Medical history of patient
Time frame: 2 years
Change in left atrial volume measured by transthoracic echocardiography
Time frame: 2 years
Change in left ventricular diastolic dysfunction measured by transthoracic echocardiography with the definition according to the leading guidelines
Time frame: 2 years
Change in left ventricular ejection fraction measured by transthoracic echocardiography
Time frame: 2 years
Change in right ventricular function measured by transthoracic echocardiography with the definition according to the leading guidelines
Time frame: 2 years
Change in diameter of epicardial fat measured by transthoracic echocardiography
Time frame: 2 years
Measured with the iMedical Consumption Questionnaire (instrument for measuring medical consumption, costs will be estimated by given answers and relation to known costs of the items of medical consumption)
Time frame: 2 years
Measured with the 5-level EQ-5D questionnaire (The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression)
Contact information is provided by the study sponsor or research team.
Michiel Rienstra, MD, PhD
CONTACT
Thomas M Gorter, MD, PhD
CONTACT
University Medical Center Groningen
Other
Bariatric Surgery Evaluation and Assessment of Treatment Efficacy in Heart Failure with Preserved Ejection Fraction - Intervention Trial
Acronym: BEAT-IT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05508256
Arrhythmias, Cardiac, Atrial Fibrillation
Berlin, Germany
View Trial DetailsNCT07254455
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsNCT06833138
Arrhythmias, Cardiac, Atrial Fibrillation
Aalst, Belgium
View Trial DetailsNCT06369298
Arrhythmias, Cardiac, Atrial Fibrillation
Alexander City, Alabama, United States
View Trial Details